فرآوردههای تزریقی ایران
دفرا | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Balance Sheet
AGM
Interim
2026/06/22 Fiscal Year 2026/03/2012 Month | 2025/06/23 Fiscal Year 2025/03/2012 Month | 2024/06/23 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 1.449 Trillion | 720.73 Billion | 312.098 Billion | |
Short-Term Investments | 620 Billion | - | 250 Billion | |
Trade Receivables | 16.993 Trillion | 9.577 Trillion | 6.048 Trillion | |
Prepayments | 526.941 Billion | 155.607 Billion | 193.488 Billion | |
Raw Materials & Packaging Inventory | 2.31 Trillion | 804.222 Billion | 907.002 Billion | |
Work-in-Progress Inventory | 14.05 Billion | 2.612 Billion | 5.945 Billion | |
Finished Goods Inventory | 215.439 Billion | 396.027 Billion | 197.628 Billion | |
Spare Parts Inventory | 235.89 Billion | 113.403 Billion | 80.131 Billion | |
Our Goods on Consignment with Others | - | - | 5.029 Billion | |
Other Inventories | 34.614 Billion | 13.234 Billion | - | |
Inventories | 2.81 Trillion | 1.329 Trillion | 1.196 Trillion | |
Total Current Assets | 22.4 Trillion | 11.783 Trillion | 7.999 Trillion | |
Long-Term Investments | 10.184 Trillion | 2.035 Trillion | 1.405 Trillion | |
Long-Term Trade Receivables | 10.425 Billion | 500 Million | 1.244 Billion | |
Intangible Assets | 78.139 Billion | 76.642 Billion | 76.808 Billion | |
Other Assets | - | - | 28.756 Billion | |
Property, Plant & Equipment | 2.985 Trillion | 2.921 Trillion | 2.595 Trillion | |
Net Fixed Assets | 2.985 Trillion | 2.921 Trillion | 2.595 Trillion | |
Total Non-Current Assets | 13.258 Trillion | 5.033 Trillion | 4.107 Trillion | |
Total Assets | 35.658 Trillion | 16.816 Trillion | 12.106 Trillion | |
Trade Payables | 3.899 Trillion | 822.316 Billion | 428.006 Billion | |
Advances Received | - | 7.604 Billion | - | |
Income Tax Provision | 3.956 Trillion | 1.769 Trillion | 1.852 Trillion | |
Proposed & Payable Dividends | 17.876 Billion | 1.581 Trillion | 731.641 Billion | |
Total Current Liabilities | 7.873 Trillion | 4.179 Trillion | 3.012 Trillion | |
Long-Term Payables | 185.381 Billion | 111.121 Billion | 92.557 Billion | |
Employee Termination Benefits Provision | 991.693 Billion | 679.198 Billion | 468.621 Billion | |
Total Non-Current Liabilities | 1.177 Trillion | 790.319 Billion | 561.178 Billion | |
Total Liabilities | 9.05 Trillion | 4.97 Trillion | 3.573 Trillion | |
Capital | 7 Trillion | 2.8 Trillion | 1.4 Trillion | |
Retained Earnings | 18.951 Trillion | 8.766 Trillion | 6.993 Trillion | |
Legal Reserve | 700 Billion | 280 Billion | 140 Billion | |
Share Premium Reserve | -42.998 Billion | - | - | |
Total Equity | 26.608 Trillion | 11.846 Trillion | 8.533 Trillion | |
Total Liabilities & Equity | 35.658 Trillion | 16.816 Trillion | 12.106 Trillion | |
Approved Capital | 7 Trillion | 2.8 Trillion | 1.4 Trillion | |
Approved Retained Earnings | 8.101 Trillion | 4.454 Trillion | 1.813 Trillion | |
Approved Legal Reserve | 700 Billion | 280 Billion | 140 Billion | |
Total Approved Equity (at AGM) | 15.801 Trillion | 7.534 Trillion | 3.353 Trillion |